🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stem Cell Transplant Complications

Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Intestinal Microbiota in Stem Cell Transplant Transplant Admission NCT04623424n/a1 site📍 Detroit Henry Ford Health System · Tests: intestinal microbiota Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants NCT06788470Phase 1, Phase 21 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: MSC Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor NCT05508009Phase 1, Phase 21 site📍 Palo Alto Alice Bertaina · Tests: Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg, Total Body Irradiation, ATG Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) NCT07509749Phase 21 site📍 Beijing Daihong Liu · Tests: Ruxolitinib and Methylprednisolone, Methylprednisolone Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation NCT07570407n/a1 site📍 Pilsen University Hospital Pilsen · Tests: blood draw Comparison of Intralipid With SMOF Lipid Following HSCT NCT06625372NA1 site📍 Tehran Shahid Beheshti University · Tests: SMOF lipid, INTRALIPIDS Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies NCT03818334Phase 2, Phase 31 site📍 São Paulo Hospital Israelita Albert Einstein · Tests: Cyclophosphamide, ATG Modified Second Haplo-transplantation for Graft Failure NCT06512545NA1 site📍 Beijing Peking University People's Hospital · Tests: second allogeneic stem cell transplantation Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation NCT07349498n/a16 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital Ocular Complications From Cancer Therapy - Patient Registry and Biobank NCT06874283n/a1 site📍 Baltimore University of Maryland, Baltimore · Tests: Eye exam Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT NCT03793517Phase 2, Phase 31 site📍 Beijing Peking University People's Hospital · Tests: Decitabine, mBU/CY and ATG, mBU/CY Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation. NCT07028112n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Cohort Loratadine for the Prevention of G-CSF-related Bone Pain NCT05421416Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Loratadine, Placebo Second Haplo-transplantation for Graft Failure NCT06512519NA1 site📍 Beijing Peking University People's Hospital · Tests: second allogeneic stem cell transplantation BMT-CARE: Psychosocial Intervention for Transplant Caregivers NCT06472089NA3 sites📍 Birmingham📍 Tampa📍 Boston Massachusetts General Hospital · Tests: BMT-CARE, Usual Care Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients NCT06468618NA2 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: DREAMS Program Video and Care Kit A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors NCT06541002NA3 sites📍 Coral Gables📍 Boston📍 Philadelphia Massachusetts General Hospital · Tests: SHIFT Intervention Group, Enhanced Usual Care Group Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial) NCT05762211Phase 254 sites📍 Antwerp📍 Bruges📍 Brussels MaaT Pharma · Tests: Pooled allogeneic fecal microbiotherapy, Placebo Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation NCT07358195EARLY Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Venetoclax, Hematopoietic Cell Transplantation Conditioning Regimen, Kidney Transplant, Hematopoietic Cell Transplantat… PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70. NCT05947136NA6 sites📍 Épagny📍 Grenoble📍 Lyon Centre Leon Berard · Tests: Interpretation of the results from the detection visit, Explaining detection results and referrals to the patient, Earl… Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants NCT05525507Phase 11 site📍 Los Angeles University of California, Los Angeles · Tests: Conditioning and Stem cell infusion PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) NCT06665100Phase 212 sites📍 Duarte📍 Atlanta📍 Baltimore Pulmotect, Inc. · Tests: PUL-042, Placebo Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD) NCT06752577n/a1 site📍 Jacksonville Mayo Clinic · Tests: Allogeneic, vertebral bone marrow-derived mesenchymal stem cells (MSC) Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET) NCT07607197Phase 1, Phase 21 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Autologous Hematopoietic Stem Cell Transplantation High Heated Humidity in Stem Cell Transplant NCT05358262Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Airvo, Standard of Care Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor NCT03214354Phase 21 site📍 Calgary University of Calgary · Tests: Alemtuzumab, Total Body Irradiation, Sirolimus Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections NCT04832607Phase 333 sites📍 Brussels📍 Brussels📍 Ghent Tobias Feuchtinger · Tests: Multivirus (CMV, EBV, AdV)-specific T cells IS-free Treg HaploHCT NCT04678401Phase 11 site📍 Boston Dana-Farber Cancer Institute · Tests: Radiation, Fludarabine, Thiotepa, Cyclophosphamide, Mesna In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome NCT05797272NA1 site📍 Shatin Chinese University of Hong Kong · Tests: in-utero HSCT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy